LENZ Therapeutics Inc.

NASDAQ: LENZ · Real-Time Price · USD
38.76
-2.15 (-5.26%)
At close: Aug 15, 2025, 3:14 PM

LENZ Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
20.16M 35.14M 47.73M 376.98M
Short-Term Investments
188.87M 150.72M 220.5M n/a
Long-Term Investments
n/a n/a 17.04M n/a
Other Long-Term Assets
1.4M 2.81M 1.29M 2.17M
Receivables
n/a n/a n/a n/a
Inventory
n/a n/a n/a n/a
Other Current Assets
114K 1.45M 2.2M 4.76M
Total Current Assets
211.92M 188.02M 275.37M 381.74M
Property-Plant & Equipment
1.99M 321K 28.21M 18.08M
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
3.39M 3.13M 46.54M 20.25M
Total Assets
215.3M 188.46M 321.9M 401.99M
Account Payables
4.26M 250K 2.26M 460K
Deferred Revenue
n/a n/a n/a n/a
Short-Term Debt
n/a 285K n/a n/a
Other Current Liabilities
n/a 2.73M 6.04M 7M
Total Current Liabilities
10.41M 4.8M 13.04M 12.14M
Long-Term Debt
n/a n/a n/a n/a
Other Long-Term Liabilities
n/a 144.5M 12.42M 31.3M
Total Long-Term Liabilities
814K 144.57M 12.57M 25.4M
Total Liabilities
11.22M 4.87M 25.61M 12.14M
Total Debt
1.38M 362K 5.79M n/a
Common Stock
1K 1K 1K 1K
Retained Earnings
-145.01M -367.05M -242.4M -141.35M
Comprehensive Income
196K n/a -1.05M -999
Shareholders Equity
204.08M 183.58M 296.29M 389.84M
Total Investments
188.87M 30.65M 237.54M n/a